Increasing Lantus Dose in Patients on Lispro
Increase Lantus by 2 units every 3 days until fasting plasma glucose reaches goal (<100 mg/dL or <5.5 mmol/L) without hypoglycemia. 1
Evidence-Based Titration Algorithm
The 2025 ADA Standards of Care provide the definitive approach for basal insulin titration 1:
Starting Point Assessment
- Set your fasting plasma glucose (FPG) target based on individualized glycemic goals
- Standard target: FPG <100 mg/dL (<5.5 mmol/L)
- Review current Lantus dose and recent FPG readings
Titration Schedule
Increase Lantus dose by 2 units every 3 days based on FPG readings until target is reached 1. This is the evidence-based standard from the ADA guidelines and is supported by the FDA label 2.
Hypoglycemia Management
- If hypoglycemia occurs: Determine the cause
- If no clear reason identified: Reduce Lantus dose by 10-20% 1
- Consider prescribing glucagon for emergent hypoglycemia 1
Signs You May Need to Add or Adjust Prandial Insulin
Monitor for clinical signals of "overbasalization" at every visit 1:
- Large bedtime-to-morning glucose differential
- Large postprandial-to-preprandial glucose differential
- Hypoglycemia (aware or unaware)
- High glucose variability
- A1C remains above goal despite adequate fasting glucose
If these signs appear, the problem is not inadequate basal insulin—you need to optimize the lispro dosing or add GLP-1 RA therapy rather than continuing to increase Lantus. 1
Practical Considerations
Timing
Lantus can be administered at any time of day, but must be given at the same time every day 2. Clinical data shows similar efficacy whether given at breakfast, dinner, or bedtime 2.
Common Pitfall
Do not continue escalating basal insulin indefinitely if A1C remains elevated despite good fasting glucose control. This leads to overbasalization, increased hypoglycemia risk, and weight gain without glycemic benefit 1. Instead, intensify prandial coverage with lispro or add adjunctive therapy.
Monitoring Frequency
Reassess and modify the regimen every 3-6 months to avoid therapeutic inertia 1. Blood glucose monitoring is essential throughout titration 2.